Last reviewed · How we verify
Vancomycin-Resistant Enterococcus Faecium Infection
Approved treatments
- Zyvox · Pfizer
Zyvox works by inhibiting the bacterial protein synthesis initiation complex, preventing the growth and replication of Gram-positive bacteria.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vancomycin-Resistant Enterococcus Faecium Infection patent landscape — cliff calendar, originator estates, attackable patents
- Vancomycin-Resistant Enterococcus Faecium Infection treatment landscape brief
- Vancomycin-Resistant Enterococcus Faecium Infection treatment updates RSS
Frequently asked questions about Vancomycin-Resistant Enterococcus Faecium Infection
What drugs treat Vancomycin-Resistant Enterococcus Faecium Infection?
Tracked treatments include Zyvox.
What is the treatment for Vancomycin-Resistant Enterococcus Faecium Infection?
Standard treatment for Vancomycin-Resistant Enterococcus Faecium Infection includes Zyvox. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Vancomycin-Resistant Enterococcus Faecium Infection patent cliff · Vancomycin-Resistant Enterococcus Faecium Infection CI report
- Treatment: Zyvox · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing